Industry News
Pharmaceutical Industry News
Perhaps the best way to think of…
Perhaps the best way to think of today’s pharma marketing landscape is as a one-way street. Information flows to healthcare professionals (HCPs) through carefully crafted communications, including emails and SMS messages, but physicians often lack
BMS is exiting the first…
BMS is exiting the first U.S.-China pharmaceutical joint venture. Two biotechs have launched with backing from big venture capital firms and Chinese assets. Roche and Johnson & Johnson are reportedly eyeing an antibody-drug conjugate deal
In addition to manufacturing drug…
In addition to manufacturing drug substance for argenx’s autoimmune blockbuster Vyvgart at its facility in Hillerød, Denmark, Fujifilm will also make the product at its large-scale complex in Holly Springs, N.C., starting in 2028.
Nearly three years after…
Nearly three years after originating the role, Erica Taylor, Ph.D., is stepping down as chief marketing officer of Genentech.
Over the last six years, three…
Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with type 2 diabetes. Now this rapidly growing patient population is a step closer to gaining access to
Bluebird bio has molted to reveal…
Bluebird bio has molted to reveal a new—or new-ish, at least—brand identity.
The duel of the GLP-1 data sets…
The duel of the GLP-1 data sets continues this week, with Novo issuing the latest salvo of updates on its oral obesity candidate and an Ozempic head-to-head trial win against another stalwart diabetes treatment. In
MilliporeSigma, a unit of…
MilliporeSigma, a unit of Germany's Merck KGaA, opened a €150 million ($177 million) filtration products plant in Cork, bolstering the company’s goal to expand global manufacturing operations.
Insulet is bringing a splash of…
Insulet is bringing a splash of color to the diabetes technology market. Working with Pantone, the insulin pump company has created the “bright and joyful tropical orange yellow” color Omnipod Mango.
Merck is stepping up to the plate…
Merck is stepping up to the plate to raise awareness of the dangers of high LDL cholesterol and how it can increase the risk of atherosclerotic cardiovascular disease (ASCVD).
Former CDC Director Susan Monarez,…
Former CDC Director Susan Monarez, Ph.D., told senators the health secretary claimed there was "no science or evidence" supporting the current childhood vaccine schedule and that he had the president's backing to impose changes without
It’s the second restructuring this…
It's the second restructuring this year for X4 Pharmaceuticals as the company moves forward under new leadership and with 50% fewer staff members.
Novo Nordisk is not wasting time…
Novo Nordisk is not wasting time beginning the layoffs it announced last week as it is dismissing 263 employees from its U.S. headquarters in Plainsboro, New Jersey. Additionally, Bristol Myers Squibb is cutting 282 workers
As patients and healthcare…
As patients and healthcare professionals alike increasingly turn to artificial intelligence tools like OpenAI’s ChatGPT and Google’s Gemini rather than traditional search engines for online research, pharma marketers will need to significantly shift their strategies
SK Biopharmaceutical is targeting…
SK Biopharmaceutical is targeting a new FDA indication in primary generalized tonic-clonic seizures for Xcopri after its original 2019 approval for focal seizures.
After another swing and a miss for…
After another swing and a miss for AstraZeneca's investigation of Fasenra in chronic obstructive pulmonary disease, the company is pivoting to other options in its portfolio that might have potential to treat the respiratory disease.
Diagnosis and treatment delays…
Diagnosis and treatment delays cost patient lives. Learn how forward-thinking pharma brands are using smarter marketing to change the picture.
British Big Pharma GSK is…
British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing.
AGC has started a “structured…
AGC has started a “structured process” to seek for buyers for its large-scale mammalian production sites in Boulder and Longmont, Colorado, a company spokesperson said.
After the FDA announced it was…
After the FDA announced it was cracking down on what it has determined to be “misleading” or “deceptive” direct-to-consumer pharmaceutical ads, the floodgates have opened.